Qyresearchreports include new market research report "Global Liraglutide Market Insights, Forecast to 2025" to its huge collection of research reports.
This report studies the global market size of Liraglutide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Liraglutide in these regions.
This research report categorizes the global Liraglutide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
To Download Sample Report with TOC: https://www.qyresearchreports.com/sample/sample.php?rep_id=1924698&type=S
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In 2017, the global Liraglutide market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Liraglutide market based on company, product type, application and key regions.
The various contributors involved in the value chain of Liraglutide include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Liraglutide include
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Market Size Split by Type
Pills
Liquid
Market Size Split by Application
Hospital
Drug Store
Browse Press Release of this Research Report: https://www.qyresearchreports.com/report/global-liraglutide-market-insights-forecast-to-2025.htm
The study objectives of this report are:
To study and analyze the global Liraglutide market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Liraglutide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Liraglutide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Liraglutide with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Liraglutide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Liraglutide are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Liraglutide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Liraglutide Manufacturers
Liraglutide Distributors/Traders/Wholesalers
Liraglutide Subcomponent Manufacturers
Industry Association
Downstream Vendors
About Us:
QYResearchReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us:
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Follow Us on LinkedIn: https://www.linkedin.com/company/qyresearchreports-com
Blog – qyresearch-group.blogspot.in
Email: sales@qyresearchreports.com
This report studies the global market size of Liraglutide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Liraglutide in these regions.
This research report categorizes the global Liraglutide market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
To Download Sample Report with TOC: https://www.qyresearchreports.com/sample/sample.php?rep_id=1924698&type=S
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In 2017, the global Liraglutide market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Liraglutide market based on company, product type, application and key regions.
The various contributors involved in the value chain of Liraglutide include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Liraglutide include
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Market Size Split by Type
Pills
Liquid
Market Size Split by Application
Hospital
Drug Store
Browse Press Release of this Research Report: https://www.qyresearchreports.com/report/global-liraglutide-market-insights-forecast-to-2025.htm
The study objectives of this report are:
To study and analyze the global Liraglutide market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Liraglutide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Liraglutide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Liraglutide with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Liraglutide submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Liraglutide are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Liraglutide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Liraglutide Manufacturers
Liraglutide Distributors/Traders/Wholesalers
Liraglutide Subcomponent Manufacturers
Industry Association
Downstream Vendors
About Us:
QYResearchReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYResearchReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.
Contact Us:
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-621-2074
Follow Us on LinkedIn: https://www.linkedin.com/company/qyresearchreports-com
Blog – qyresearch-group.blogspot.in
Email: sales@qyresearchreports.com
No comments:
Post a Comment